“…Three types of relapse were observed: development of a multiple myeloma (54%), local relapse (11%), appearance of new lesions (multiple plasmacytomas) in the absence of multiple myeloma (2%). The main predictors of recurrence are tumor size and the dose of radiotherapy delivered, with a higher risk for tumors larger than 5 cm and in case of radiotherapy with a dose less than or equal to 35 Gy [10] .…”